The study for new therapy of endotoxin shock

内毒素休克新疗法的研究

基本信息

项目摘要

We were able to immobilize Polymyxin B through condensation or by inducing in to react with halogen. A much larger dose of Polymyxin B adhered to one gr of polystyrene fiber after the condensation reaction than it did following the halogen reaction. Fixed polymyxin B was found to be firmly attached to the fiber. The mortality of mice after injection of PMX-F treated fluid contained endotoxin, indicated that 24 % (5 of 21) of the treated group survived. Whereas 100 % (21 of 21) of the untreated group died. In ex vivo experiments, direct hemoperfusion (DHP) by PMX-F was performed for endotoxin-injected canine. Only 12.5 % (1 of 8) survived in the control group, but 83 % (10 of 12) survived in the treated group receiving DHP with PMX-F. Mortality in the treated group decreased remarkably. The results thus indicated the efficacy of PMX-F in neutralizing endotoxin.For the clinical application, PMX-F is being estimated blood compatibility with larger column for human. And DHP using PMX-F is tried by smaller amount of heparin than that of earlier examination. DHP can be driven safely with this quantity of heparin in animal.
我们能够通过缩合或通过引入与卤素反应来制备多粘菌素B。在缩合反应后,粘附到1克聚苯乙烯纤维上的多粘菌素B的剂量比在卤素反应后大得多。发现固定的多粘菌素B牢固地附着在纤维上。注射含有内毒素的PMX-F处理的液体后小鼠的死亡率表明,处理组中有24%(21只中的5只)存活。而未治疗组100%(21/21)死亡。在离体实验中,通过PMX-F对注射内毒素的犬进行直接血液灌流(DHP)。对照组中仅12.5%(1/8)存活,但接受DHP和PMX-F的治疗组中83%(10/12)存活。治疗组病死率明显降低。因此,PMX-F具有中和内毒素的作用,为临床应用,PMX-F正在进行人体血液相容性评价。使用PMX-F的DHP比早期检查的肝素量更少。在动物体内使用此量的肝素可以安全地驱动DHP。

项目成果

期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
小玉正智 他: 人工臓器.
Masatomo Kodama 等人:人造器官。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
小玉正智 他: 人工臓器. 14. 590-594 (1985)
Masatomo Kodama 等:人工器官。14. 590-594 (1985)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
小玉正智 他: 免疫と血液. 7. 427-432 (1985)
Masatomo Kodama 等人:免疫与血液。7. 427-432 (1985)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Kodama;T.Yoshioka;Y.Endo;T.Tani;K.Hanasawa;T.Oka;K.Matsuda: Journal of Immunology and Immunopharmacology. 6. 224 (1986)
M.Kodama;T.Yoshioka;Y.Endo;T.Tani;K.Hanasawa;T.Oka;K.Matsuda:免疫学和免疫药理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M. Kodama et al.: "Studies on Prevention to MOF -Removal of Endotoxin in Serum on Hepatic Disorder" Jpn. J. Artif Organs. 14. 590-594 (1985)
M. Kodama等:“预防MOF的研究-肝脏疾病血清中内毒素的去除”Jpn。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KODAMA Masashi其他文献

KODAMA Masashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KODAMA Masashi', 18)}}的其他基金

Development of Hybrid Artificial Liver with Isolated Hepatocytes in Extracorporeal Circulation
体外循环分离肝细胞混合人工肝的研制
  • 批准号:
    06454381
  • 财政年份:
    1994
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Studies on the Inhibitory Effect of Blood Transfusion Against Anti-Tumor Immunity
输血抗肿瘤免疫抑制作用的研究
  • 批准号:
    01480312
  • 财政年份:
    1989
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
evaluation and invention of endotoxin detoxifying material for clinical application
内毒素解毒材料的临床应用评价及发明
  • 批准号:
    62870051
  • 财政年份:
    1987
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Study on the mechanical analysis of septic shock and its theraputic strategy
感染性休克的力学分析及治疗策略研究
  • 批准号:
    62480271
  • 财政年份:
    1987
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Protection against endotoxin shock though stabilization of macrophages by platelet-derived factors
通过血小板衍生因子稳定巨噬细胞来防止内毒素休克
  • 批准号:
    17K08393
  • 财政年份:
    2017
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of molecular mechanism of orexin on the brain in endotoxin shock
阐明内毒素休克脑内食欲素的分子机制
  • 批准号:
    16K08541
  • 财政年份:
    2016
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of Prolyl Hydroxylase Improves Myocardial Dysfunction Following Endotoxin Shock via Activation of Kynurenic Acid Production
抑制脯氨酰羟化酶通过激活犬尿酸生成改善内毒素休克后的心肌功能障碍
  • 批准号:
    16K20400
  • 财政年份:
    2016
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation of the mechanism of low-affinity anti-histone H1 monoclonal antibody that rescues mice from lethal endotoxin shock
低亲和力抗组蛋白H1单克隆抗体拯救小鼠致死性内毒素休克的机制研究
  • 批准号:
    26861531
  • 财政年份:
    2014
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The effect of extracellular ATP on LPS-induced endotoxin shock in mice.
细胞外 ATP 对 LPS 诱导的小鼠内毒素休克的影响。
  • 批准号:
    21790381
  • 财政年份:
    2009
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The effect of resolvin D1 on D-galactosamine-primed endotoxin shock model in mice.
Resolvin D1 对小鼠 D-半乳糖胺引发的内毒素休克模型的影响。
  • 批准号:
    20790341
  • 财政年份:
    2008
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    7173831
  • 财政年份:
    2005
  • 资助金额:
    $ 3.52万
  • 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    7392241
  • 财政年份:
    2005
  • 资助金额:
    $ 3.52万
  • 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    6917375
  • 财政年份:
    2005
  • 资助金额:
    $ 3.52万
  • 项目类别:
C1 INHIBITOR-MEDIATED PROTECTION FROM ENDOTOXIN SHOCK
C1 抑制剂介导的内毒素休克保护
  • 批准号:
    7544502
  • 财政年份:
    2005
  • 资助金额:
    $ 3.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了